OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Psychopharmacology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping	88
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review	52
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital	45
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness	43
Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis	42
History repeating: guidelines to address common problems in psychedelic science	40
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study	38
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial	33
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study	30
Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit	24
Comment on: History repeating: guidelines to address common problems in psychedelic science	24
Psychotropic medications versus non-pharmacologic approaches for managing behavioural and psychological symptoms in Australian aged care residents with dementia: general practitioners’ and physicians’	23
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study	23
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system	22
The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes	22
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”	21
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry	19
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?	19
Reasons for admission to a general medical hospital for patients taking clozapine	18
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia	18
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review	16
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?	16
Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, s	15
Risperidone-induced priapism: a case report and literature review	15
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review	15

Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey	15
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications	14
Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors	14
Will psilocybin lose its magic in the clinical setting?	13
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand	13
Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine	13
Risperidone-induced neuroleptic malignant syndrome: a case report	13
Impact of CYP1A , CYP2C19 , CYP2D6 , CYP3A4 , CYP3A5	13
Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’	12
Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic review	11
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia	10
Anticholinergic action is rarely a good thing	10
Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records	9
Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders	8
High-dose olanzapine in treatment-resistant schizophrenia: a systematic review	8
The role of empathy in antidepressant withdrawal	8
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies	8
Decreased citalopram concentration caused by enzyme induction effect of rifampin: a case report	8
Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomes	8